169 related articles for article (PubMed ID: 35294262)
1. Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
Freyer DR; Lin L; Mack JW; Maurer SH; McFatrich M; Baker JN; Jacobs SS; Lucas N; Withycombe JS; Tomlinson D; Villabroza KR; Waldron MK; Hinds PS; Reeve BB
J Clin Oncol; 2022 May; 40(15):1623-1634. PubMed ID: 35294262
[TBL] [Abstract][Full Text] [Related]
2. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
Reeve BB; McFatrich M; Lin L; Lucas NR; Mack JW; Jacobs SS; Withycombe JS; Baker JN; Freyer DR; Hinds PS
Cancer; 2021 May; 127(9):1483-1494. PubMed ID: 33332590
[TBL] [Abstract][Full Text] [Related]
3. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
[TBL] [Abstract][Full Text] [Related]
4. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
[TBL] [Abstract][Full Text] [Related]
5. Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials.
Maurer SH; Hinds PS; Reeve BB; Mack JW; McFatrich M; Lin L; Withycombe JS; Jacobs SS; Baker JN; Castellino SM; Freyer DR
Cancer; 2021 Oct; 127(19):3664-3670. PubMed ID: 34196962
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C; Hinds PS; Reeve BB
Pediatr Blood Cancer; 2022 Dec; 69(12):e29986. PubMed ID: 36151978
[TBL] [Abstract][Full Text] [Related]
7. Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events.
Hinds PS; Pinheiro LC; McFatrich M; Waldron M; Baker JN; Mowbray C; Maurer SH; Cheng Y; Reeve BB; Wang J
Pediatr Blood Cancer; 2022 Jun; 69(6):e29452. PubMed ID: 34866311
[TBL] [Abstract][Full Text] [Related]
8. Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
Veitch ZW; Shepshelovich D; Gallagher C; Wang L; Abdul Razak AR; Spreafico A; Bedard PL; Siu LL; Minasian L; Hansen AR
J Natl Cancer Inst; 2021 Aug; 113(8):980-988. PubMed ID: 33616650
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.
Dueck AC; Scher HI; Bennett AV; Mazza GL; Thanarajasingam G; Schwab G; Weitzman AL; Rogak LJ; Basch E
JAMA Oncol; 2020 Feb; 6(2):e193332. PubMed ID: 31556911
[TBL] [Abstract][Full Text] [Related]
10. Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
Liu L; Suo T; Shen Y; Geng C; Song Z; Liu F; Wang J; Xie Y; Zhang Y; Tang T; Zhang L; Wang W
Qual Life Res; 2020 Nov; 29(11):3009-3015. PubMed ID: 32564293
[TBL] [Abstract][Full Text] [Related]
11. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.
Atkinson TM; Ryan SJ; Bennett AV; Stover AM; Saracino RM; Rogak LJ; Jewell ST; Matsoukas K; Li Y; Basch E
Support Care Cancer; 2016 Aug; 24(8):3669-76. PubMed ID: 27260018
[TBL] [Abstract][Full Text] [Related]
12. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
Basch E; Dueck AC; Rogak LJ; Minasian LM; Kelly WK; O'Mara AM; Denicoff AM; Seisler D; Atherton PJ; Paskett E; Carey L; Dickler M; Heist RS; Himelstein A; Rugo HS; Sikov WM; Socinski MA; Venook AP; Weckstein DJ; Lake DE; Biggs DD; Freedman RA; Kuzma C; Kirshner JJ; Schrag D
JAMA Oncol; 2017 Aug; 3(8):1043-1050. PubMed ID: 28208174
[TBL] [Abstract][Full Text] [Related]
13. Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events.
Speck RM; Lenderking WR; Shaw JW
J Patient Rep Outcomes; 2017; 2():35. PubMed ID: 30175317
[TBL] [Abstract][Full Text] [Related]
14. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
[TBL] [Abstract][Full Text] [Related]
15. Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
Mack JW; McFatrich M; Withycombe JS; Maurer SH; Jacobs SS; Lin L; Lucas NR; Baker JN; Mann CM; Sung L; Tomlinson D; Hinds PS; Reeve BB
JAMA Pediatr; 2020 Nov; 174(11):e202861. PubMed ID: 32832975
[TBL] [Abstract][Full Text] [Related]
16. Symptom Adverse Events and Quality of Life of Children With Advanced Cancer: Results From a Longitudinal Study Using the Pediatric Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events.
Grinde K; Raybin JL; Ward J; Smith C; Brown R; Montgomery KE
J Pediatr Hematol Oncol Nurs; 2024; 41(1):5-15. PubMed ID: 37697734
[No Abstract] [Full Text] [Related]
17. Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
Snyder RA; Dueck AC; Fruth B; Shi Q; Hubbard JM; Herman JM; O'Reilly EM; Katz MHG
Ann Surg; 2023 Oct; 278(4):598-608. PubMed ID: 37334719
[TBL] [Abstract][Full Text] [Related]
18. Subjective Toxicity Profiles of Children in Treatment for Cancer: A New Guide to Supportive Care?
Hinds PS; Weaver MS; Withycombe JS; Baker JN; Jacobs SS; Mack JW; Maurer SH; McFatrich M; Pinheiro LC; Reeve BB; Wang J
J Pain Symptom Manage; 2021 Jun; 61(6):1188-1195.e2. PubMed ID: 33096220
[TBL] [Abstract][Full Text] [Related]
19. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Chung AE; Shoenbill K; Mitchell SA; Dueck AC; Schrag D; Bruner DW; Minasian LM; St Germain D; O'Mara AM; Baumgartner P; Rogak LJ; Abernethy AP; Griffin AC; Basch EM
J Am Med Inform Assoc; 2019 Apr; 26(4):276-285. PubMed ID: 30840079
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
Watson GA; Veitch ZW; Shepshelovich D; Liu ZA; Spreafico A; Abdul Razak AR; Bedard PL; Siu LL; Minasian L; Hansen AR
Br J Cancer; 2022 Nov; 127(9):1629-1635. PubMed ID: 36008705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
